Search Results 31-40 of 16571 for ������������KA���:ZA31���24������ ���������������������������������

  1. Family planning: Get the facts about pregnancy spacing - Mayo Clinic

    For most people, it's best to wait 18 to 24 months but less than five years after a live birth before getting pregnant again. This lowers the risk of health ...

  2. Predicting the Safety and Effectiveness of Inferior Vena Cava Filters - Mayo Clinic

    All treated subjects will be evaluated at procedure, 3-months, 6-months (phone), 12-months, 18-months (phone), and 24-months post-procedure. The primary ...

  3. Sulfamethoxazole and trimethoprim (oral route) - Mayo Clinic

    Weighing 32 kg—4 teaspoonfuls (20 mL) or 2 tablets (or 1 DS tablet) 4 times a day for 14 to 21 days. Weighing 24 kg—3 teaspoonfuls (15 mL) or 1 ½ tablets 4 ...

  4. Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

  5. A Study of Patient Centered Approaches to Gene Editing - Mayo Clinic

    Overview. Tab Title Description. Study IDs. Study IDs. Site IRB. Jacksonville, Florida: 24-005545; Rochester, Minnesota: 24-005545. About this study. The ...

  6. Oncology (Medical) - Clinical trials - Mayo Clinic

    This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC).

  7. Publications - Zvonimir S. Katusic, M.D., Ph.D. - Mayo Clinic

    Nath KA, Garovic VD, Grande JP, Croatt AJ ... 2011 Mar; 300(3):H718-24. Epub 2010 Dec 10. View ... Katusic ZS, d'Uscio LV, Nath KA. Vascular ...

  8. Publications - Tracy E. Harrison, M.D. - Mayo Clinic

    2013 Sep; 40(3):509-24. Epub 2013 Jul 17. View PubMed; Weiss KE, Hahn A, Wallace DP, Biggs B, Bruce BK, Harrison TE. Acceptance of pain: associations with ...

  9. Surgical Drain Fluid for Detection of Molecular Residual Disease (MRD) in Bladder, Renal and Urothelial Cancers - Mayo Clinic

    Rochester, Minnesota: 24-013778. Sponsor Protocol Number: 24-013. About this study. The purpose of this study is to investigate if DNA cancer-associated ...

  10. ... 24 hrs (6 yrs) 52 mg intrauterine device,959.24 636000003,50419042401,levonorgestreL 17.5 mcg/24 hrs (5yrs) 19.5mg intrauterine device,"1,907.02 ...